search
Back to results

ENDO GIA™ Stapler With ENDO GIA™ Reload With Tri-Staple™ Technology in a Pulmonary Resection

Primary Purpose

Lung Cancer

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ENDO GIA™ Stapler with TRI-STAPLE™ Technology
Sponsored by
Medtronic - MITG
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lung Cancer focused on measuring lung cancer, lobectomy, wedge resection

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • The subject must be 18 years of age or older.
  • The subject must be scheduled to undergo wedge resection or lobectomy via Video Assisted Thoracoscopic Surgery (VATS) for a lung nodule suspicious for or clinically proven to be primary lung cancer.
  • The subject must be able to tolerate general anesthesia and have cardiopulmonary reserve to tolerate the procedure.
  • The subject must be willing and able to comply with all study requirements and have understood and signed the informed consent.

Exclusion Criteria:

  • The subject is pregnant or breastfeeding.
  • The subject is scheduled to undergo sleeve lobectomy, segmentectomy, bi-lobectomy, pneumonectomy or Lung Volume Reduction Surgery (LVRS), or lung biopsy for suspected interstitial lung disease.
  • A rib-spreading thoracotomy incision is scheduled to be performed, however the use of an access incision without rib-spreading for specimen removal or to facilitate hilar dissection is allowed. VATS procedures that are converted in the operating room to open procedures are not exclusionary.
  • The subject has received pre-operative chemotherapy or radiation therapy for the lung cancer that will be resected.
  • The subject is scheduled to receive intra-operative brachytherapy.
  • The subject has other severe illnesses that would preclude surgery such as unstable angina or myocardial infarction within 3 months.
  • Re-operative surgery is excluded if it is on the same side as the previous surgery.
  • Investigator determines that participation in the study may jeopardize the safety or welfare of the subject.
  • The subject is unable to comply with the follow-up visit schedule

Sites / Locations

  • Cedar Sinai Medical Center
  • Advocate Christ Medical Center
  • Mayo Clinic

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

ENDO GIA™ Stapler with TRI-STAPLE™ Technology

Arm Description

Single arm study, all patients will receive the study device.

Outcomes

Primary Outcome Measures

Incidence of Prolonged Air Leaks
Defined as > 5 days by the Society for Thoracic Surgery

Secondary Outcome Measures

Incidence of Air Leaks
As recorded on the air leak log.
Duration of Air Leak
Measured in days. For patients discharged from the hospital with a Heimlich valve, the duration will be censored on the date of discharge.
Length of Hospital Stay
Duration of Chest Tube Following Surgery
Chest tube duration was calculated as removal date - placement date + 1
Incidence of Serosal Tearing

Full Information

First Posted
October 18, 2010
Last Updated
June 3, 2014
Sponsor
Medtronic - MITG
search

1. Study Identification

Unique Protocol Identification Number
NCT01241565
Brief Title
ENDO GIA™ Stapler With ENDO GIA™ Reload With Tri-Staple™ Technology in a Pulmonary Resection
Official Title
A Prospective, Multi-Center Evaluation of the ENDO GIA™ Stapler With ENDO GIA™ Reload With Tri-Staple™ Technology in a Pulmonary Resection
Study Type
Interventional

2. Study Status

Record Verification Date
June 2014
Overall Recruitment Status
Completed
Study Start Date
November 2010 (undefined)
Primary Completion Date
October 2011 (Actual)
Study Completion Date
October 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medtronic - MITG

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The objectives of this clinical trial are to compare the incidence and duration of air leaks and the incidence of prolonged air leaks (defined as > 5 days by the Society for Thoracic Surgery) when using the ENDO GIA™ Stapler with ENDO GIA™ SULU with TRI-STAPLE™ Technology in a pulmonary resection via Video Assisted Thoracoscopic Surgery (VATS).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Cancer
Keywords
lung cancer, lobectomy, wedge resection

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ENDO GIA™ Stapler with TRI-STAPLE™ Technology
Arm Type
Experimental
Arm Description
Single arm study, all patients will receive the study device.
Intervention Type
Device
Intervention Name(s)
ENDO GIA™ Stapler with TRI-STAPLE™ Technology
Intervention Description
All patients will have surgery with ENDO GIA™ Stapler with TRI-STAPLE™ Technology
Primary Outcome Measure Information:
Title
Incidence of Prolonged Air Leaks
Description
Defined as > 5 days by the Society for Thoracic Surgery
Time Frame
Day 30
Secondary Outcome Measure Information:
Title
Incidence of Air Leaks
Description
As recorded on the air leak log.
Time Frame
Day 30
Title
Duration of Air Leak
Description
Measured in days. For patients discharged from the hospital with a Heimlich valve, the duration will be censored on the date of discharge.
Time Frame
Day 30
Title
Length of Hospital Stay
Time Frame
Approximately Day 6
Title
Duration of Chest Tube Following Surgery
Description
Chest tube duration was calculated as removal date - placement date + 1
Time Frame
Approximately Day 5
Title
Incidence of Serosal Tearing
Time Frame
Day 30

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The subject must be 18 years of age or older. The subject must be scheduled to undergo wedge resection or lobectomy via Video Assisted Thoracoscopic Surgery (VATS) for a lung nodule suspicious for or clinically proven to be primary lung cancer. The subject must be able to tolerate general anesthesia and have cardiopulmonary reserve to tolerate the procedure. The subject must be willing and able to comply with all study requirements and have understood and signed the informed consent. Exclusion Criteria: The subject is pregnant or breastfeeding. The subject is scheduled to undergo sleeve lobectomy, segmentectomy, bi-lobectomy, pneumonectomy or Lung Volume Reduction Surgery (LVRS), or lung biopsy for suspected interstitial lung disease. A rib-spreading thoracotomy incision is scheduled to be performed, however the use of an access incision without rib-spreading for specimen removal or to facilitate hilar dissection is allowed. VATS procedures that are converted in the operating room to open procedures are not exclusionary. The subject has received pre-operative chemotherapy or radiation therapy for the lung cancer that will be resected. The subject is scheduled to receive intra-operative brachytherapy. The subject has other severe illnesses that would preclude surgery such as unstable angina or myocardial infarction within 3 months. Re-operative surgery is excluded if it is on the same side as the previous surgery. Investigator determines that participation in the study may jeopardize the safety or welfare of the subject. The subject is unable to comply with the follow-up visit schedule
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert McKenna, MD
Organizational Affiliation
Cedar Sinai Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cedar Sinai Medical Center
City
Los Angeles
State/Province
California
ZIP/Postal Code
90048
Country
United States
Facility Name
Advocate Christ Medical Center
City
Oak Lawn
State/Province
Illinois
ZIP/Postal Code
60453
Country
United States
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States

12. IPD Sharing Statement

Learn more about this trial

ENDO GIA™ Stapler With ENDO GIA™ Reload With Tri-Staple™ Technology in a Pulmonary Resection

We'll reach out to this number within 24 hrs